Knee Arthroscopy — Cost, Top Hospitals & Success Rates | MyMedicPlus

Knee arthroscopy is a minimally invasive surgical procedure in which a thin fibre-optic camera (arthroscope, 4-5 mm diameter) is inserted into the knee joint through small incisions (portals, typically 5-7 mm), allowing the surgeon to directly visualise and treat intra-articular structures. The technique was pioneered by Masaki Watanabe in the 1950s-60s and has since become one of the most frequently performed orthopaedic procedures worldwide, with approximately 4 million knee arthroscopies performed globally each year.

The primary therapeutic applications of knee arthroscopy are: anterior cruciate ligament (ACL) reconstruction; meniscal repair or partial meniscectomy; articular cartilage procedures (microfracture, osteochondral autograft transfer, matrix-associated autologous chondrocyte implantation); synovectomy; loose body removal; lateral retinacular release; patellofemoral chondroplasty; and tibial plateau fracture fixation. The scope of arthroscopic surgery has expanded substantially with advances in instrumentation, implant technology, and surgeon training.

The diagnostic role of knee arthroscopy has, however, been dramatically curtailed by high-resolution MRI, which now provides excellent non-invasive visualisation of the ACL, PCL, menisci, articular cartilage, and supporting structures with sensitivity exceeding 90% for most pathologies. Pure diagnostic arthroscopy — performed solely to assess intra-articular structures without planned treatment — is rarely justified and is considered inappropriate in most contemporary guidelines.

Knee arthroscopy is typically performed under general or spinal anaesthesia as a day surgery (ambulatory) procedure. A tourniquet is inflated on the thigh to create a bloodless operative field. Saline irrigation continuously distends the joint, improving visualisation and removing blood and debris. Instruments — shavers, electrocautery devices, graspers, suture passers — are introduced through additional portals as needed. Most procedures are completed in 20-90 minutes depending on complexity.

This guide addresses the major therapeutic indications for knee arthroscopy with reference to the current evidence base, including landmark trials that have reshaped practice guidelines in meniscal surgery.

Knee arthroscopy addresses a spectrum of intra-articular pathologies. The conditions and the corresponding arthroscopic procedures are outlined below, with evidence quality noted where particularly relevant.

Anterior Cruciate Ligament (ACL) Tear: ACL rupture — most commonly from a non-contact pivoting mechanism in sport, or from direct contact trauma — causes immediate knee haemarthrosis, instability, and inability to perform cutting and pivoting activities. ACL tears do not heal without surgical reconstruction because the ligament lies within the joint (intra-articular) in a synovial fluid environment that prevents fibrovascular healing. ACL reconstruction (ACLR) replaces the torn ligament with a graft and is the procedure responsible for the largest volume of knee arthroscopy worldwide.

Meniscal Tears: The medial and lateral menisci — C-shaped fibrocartilage structures between the femoral and tibial condyles — serve critical functions in load distribution, joint lubrication, and stability. Meniscal tears are classified as traumatic (acute, in young active patients, from twisting injuries) or degenerative (horizontal cleavage, complex, or flap tears associated with early osteoarthritis in middle-aged patients). Treatment approach differs fundamentally by tear type and is discussed in detail under treatment options.

Articular Cartilage Lesions: Full-thickness chondral defects (osteochondral lesions) of the femoral condyle or trochlea — from acute trauma, osteochondritis dissecans (OCD), or progressive wear — cause pain, swelling, and mechanical symptoms including catching and locking. Arthroscopic cartilage repair or restoration procedures address symptomatic focal defects.

Synovial Pathology: Inflammatory synovial conditions including rheumatoid arthritis, pigmented villonodular synovitis (PVNS), and synovial chondromatosis cause progressive joint damage if untreated. Arthroscopic synovectomy debulks the pathological synovium; however, for inflammatory arthritides, biological DMARD therapy has largely superseded surgical synovectomy in disease management.

Loose Bodies: Intra-articular loose bodies — fragments of cartilage or osteochondral tissue floating freely in the joint — cause intermittent locking, catching, and pain. Arthroscopic removal is highly effective and minimally invasive.

Plica Syndrome: Symptomatic medial patellar plica — a persistent embryological synovial fold that impinges between the patella and medial femoral condyle — is treated by arthroscopic plica release when conservative management fails.

Eligibility for knee arthroscopy depends heavily on the specific indication, patient age, activity level, comorbidities, and the strength of the evidence base for the planned procedure. The era of uncritical arthroscopic debridement for all knee pain has been definitively closed by landmark RCT evidence.

ACL Reconstruction — Ideal Candidates: Active individuals under 50 — particularly those wishing to return to sport involving pivoting, cutting, and jumping — are the strongest candidates for ACLR. Age alone is not a contraindication; ACL reconstruction in active patients over 50 with minimal arthritic change yields outcomes comparable to younger patients. Non-operative management (rehabilitation, bracing, activity modification) is a valid alternative for less active individuals willing to avoid sports requiring rotational loading. ACL-deficient knees left unreconstructed in active individuals sustain progressive meniscal and cartilage damage over time, supporting early reconstruction in those wishing to remain active.

Meniscal Tear — Evidence-Based Patient Selection: This is the area where eligibility criteria have been most substantially revised. The METEOR trial (NEJM, 2013) and Finnish FINN trial (NEJM, 2013) demonstrated that arthroscopic partial meniscectomy for degenerative meniscal tears (in patients over 45 with early or no radiographic OA) was not superior to sham surgery or physiotherapy. These landmark findings confirm that degenerative meniscal tears in middle-aged patients with knee pain should initially be managed with supervised exercise rehabilitation, not arthroscopy. Arthroscopy is appropriate for: (1) traumatic meniscal tears (acute vertical longitudinal tears in young patients, often associated with ACL tears); (2) symptomatic locked knees where displaced bucket-handle tears prevent full extension; and (3) failure of 3-6 months of conservative management in appropriate cases after careful shared decision-making.

Cartilage Procedures — Eligibility: Ideal candidates for cartilage restoration have symptomatic isolated full-thickness chondral defects (ICRS Grade 3-4) of 2-10 cm2, are under 50, have a stable knee, and have failed conservative management. Background osteoarthritis is a relative contraindication to cartilage repair — the restored cartilage is unlikely to survive in a globally arthritic environment.

Pre-operative Assessment: All candidates should have standing AP, lateral, and skyline X-rays to assess joint space narrowing, alignment, and bony changes. MRI provides soft-tissue characterisation. Significant varus or valgus malalignment should be corrected with osteotomy before or concurrent with cartilage procedures. Bleeding disorders, active infection, and severe medical comorbidities require individual assessment.

Knee arthroscopy encompasses a diverse range of procedures. The major techniques are described below.

ACL Reconstruction — Graft Selection: The choice of ACL graft is one of the most discussed topics in sports medicine. The main options are:

• Bone-Patellar Tendon-Bone (BPTB) autograft: Long considered the gold standard — the central third of the patellar tendon with bone plugs at each end provides excellent initial fixation (bone-to-bone healing in the tunnel) and high tensile strength. Return-to-sport rates and long-term outcomes are excellent. Main drawbacks are anterior knee pain (kneeling pain), risk of patellar fracture, and quadriceps weakness in rehabilitation. The STABILITY trial (Circulation, 2019) showed BPTB to have slightly lower failure rates than hamstring grafts in young active patients.
• Hamstring Autograft (quadrupled semitendinosus ± gracilis): Lower donor-site morbidity at the knee, less anterior knee pain, and technically versatile. Tunnel integration relies on soft tissue-to-bone healing (slower than bone-to-bone) and fixation with interference screws or cortical buttons. The STABILITY trial demonstrated that hamstring grafts have a statistically higher re-rupture rate in young patients (under 25) returning to pivoting sports — the re-rupture rate was 25% for hamstring vs 14% for BPTB in this high-risk group. For older or less active patients, outcomes are equivalent.
• Quadriceps Tendon Autograft: An increasingly popular alternative combining the strength and bone plug option of BPTB with lower kneeling-pain donor site morbidity. Growing evidence supports equivalence with BPTB; now preferred by many high-volume ACL surgeons.
• LARS Synthetic Ligament (Ligament Augmentation and Reconstruction System): A polyethylene terephthalate synthetic graft designed for biological in-growth. Used in older patients where rapid return to activity is prioritised and in revision settings. Concerns about long-term synovitis (from synthetic debris) and high failure rates at 10+ years limit its use to selected populations. Not recommended as primary choice in young athletes by current ESSKA guidelines.
• Allograft: Cadaveric ACL, patellar tendon, or Achilles tendon allografts avoid donor site morbidity but carry higher re-rupture rates in young active patients (particularly irradiated allografts) and infectious risk. Best reserved for older patients and revision surgery.

Meniscal Procedures:

• Meniscal Repair: Vertical sutures placed arthroscopically using inside-out, outside-in, or all-inside techniques repair vertical longitudinal tears in the peripheral vascular zone (red-red zone, >3 mm from the capsule). Healing rates are 85-90% in stable knees with vascular zone tears in young patients. Concurrent ACL reconstruction significantly improves meniscal repair healing rates (from 60% to 85%+) — the biological environment of ACL reconstruction facilitates repair healing.
• Partial Meniscectomy: Removal of the unstable, torn meniscal fragment while preserving as much meniscal tissue as possible. Appropriate for irreparable tears, complex degenerative tears, and bucket-handle tears with significant tissue degeneration. Meniscal tissue is irreplaceable once removed; every square millimetre preserved reduces the accelerated osteoarthritis that follows meniscectomy.
• Meniscal Allograft Transplantation (MAT): For young patients (<50) with post-meniscectomy syndrome (pain from joint-compartment overload after prior meniscectomy), MAT replaces the missing meniscus with a sized cadaveric allograft. Outcomes show significant pain reduction and functional improvement, with graft survival of 70-80% at 10 years. MAT requires a well-aligned, stable knee for optimal results.

Articular Cartilage Procedures:

• Microfracture: Perforating subchondral bone with an arthroscopic awl to stimulate fibrocartilage in-fill from marrow stem cells. Simple, inexpensive, but produces biomechanically inferior fibrocartilage rather than hyaline cartilage; outcomes deteriorate after 2-5 years. Appropriate for smaller defects (<2 cm2) in younger patients as a first-line cartilage procedure.
• Osteochondral Autograft Transfer (OATS/Mosaicplasty): Harvesting osteochondral plugs from low-weight-bearing areas of the knee and transplanting them into the defect. Provides true hyaline cartilage restoration. Limited by donor site availability — defects above 4 cm2 exceed practical harvesting limits.
• Matrix-Associated Autologous Chondrocyte Implantation (MACI/ACI): A two-stage procedure: (1) arthroscopic biopsy of chondrocytes, which are cultured in a laboratory for 6 weeks; (2) arthrotomy (open surgery) to implant the expanded chondrocytes in a collagen scaffold (MACI). Provides hyaline-like cartilage restoration in larger defects (2-10 cm2). NICE technology appraisal supports MACI for symptomatic femoral condyle defects where previous treatments have failed.

When applied to appropriate indications, knee arthroscopy delivers meaningful clinical benefits — return to sport, pain relief, and avoidance of major open surgery — that justify its role in the orthopaedic armamentarium.

ACL Reconstruction Outcomes: Successful ACL reconstruction restores knee stability, allowing return to pivoting and cutting sports in 85-90% of patients. The rate of return to pre-injury level of sport at 12 months is approximately 60-65% — lower than commonly perceived — reflecting the importance of psychological readiness and rehabilitation quality alongside graft biology. The risk of ACL re-rupture (graft failure) averages 5-10% overall; in young athletes under 25 returning to high-risk sports, re-rupture rates are 15-25% with hamstring grafts (vs 10-14% with BPTB per the STABILITY trial). Contralateral ACL tear risk is equally elevated in the same demographic, emphasising the importance of bilateral neuromuscular training.

Meniscal Repair Outcomes: When performed in appropriate cases (acute traumatic tears in young patients with vascular zone tears), meniscal repair achieves healing rates of 85-90% with resolution of mechanical symptoms. Repaired menisci appear to provide superior protection against subsequent cartilage degeneration compared to meniscectomy — preserving meniscal volume is the primary goal of modern meniscal surgery.

Cartilage Restoration: MACI achieves clinically significant and durable improvement in pain and function for symptomatic femoral condyle defects, with benefits maintained at 5 and 10 years in prospective studies. Microfracture provides rapid short-term benefit with acceptable outcomes at 2 years; longer-term results are inferior for larger defects.

Minimally Invasive Advantages: Compared to open knee surgery (arthrotomy), arthroscopy provides equivalent or superior intra-articular access with smaller incisions, less pain, lower infection risk, faster rehabilitation, and day-surgery feasibility. Hospital admission is typically 0-23 hours. Patients are weight-bearing immediately or within days depending on procedure.

Simultaneous Pathology Management: Arthroscopy enables treatment of multiple pathologies in a single anaesthetic episode. ACL reconstruction with concurrent medial meniscal repair — the most common combined procedure — avoids the need for staged procedures and takes advantage of the biological milieu of ACL reconstruction to improve meniscal healing.

Knee arthroscopy is a safe procedure with a low overall complication rate, but both anaesthetic and surgery-specific risks must be discussed during informed consent.

General Surgical Risks: Anaesthetic complications (respiratory, cardiovascular) are proportional to patient comorbidities; regional anaesthesia (spinal block) is preferred in higher-risk patients. Wound infection occurs in approximately 0.1-0.4% of knee arthroscopies — substantially lower than open knee surgery. Thromboembolic events (DVT, pulmonary embolism) carry a risk of approximately 0.5-1% following ACL reconstruction; prophylactic low-molecular-weight heparin is used in many protocols for 2 weeks post-operatively, particularly for higher-risk patients. Tourniquet-related nerve injury (neurapraxia) from prolonged inflation occurs in <1% of cases.

ACL Reconstruction-Specific Complications:

• Graft failure (re-rupture): 5-10% overall; 15-25% in young athletes under 25 with hamstring grafts returning to pivoting sport. Risk factors include young age, female sex, early return to sport (<9 months), insufficient quadriceps strength recovery (<90% limb symmetry index), and high-risk sport (football, basketball, skiing).
• Arthrofibrosis: Excessive scar tissue formation causing loss of knee extension — occurs in 1-5% of ACL reconstructions, particularly when surgery is performed in the acute inflammatory phase after injury (<3 weeks) or when rehabilitation is delayed.
• Donor site pain: Anterior knee pain from BPTB harvest occurs in 10-25% of patients and is the most common long-term complaint of BPTB ACL reconstruction. Quadriceps atrophy and hamstring weakness from hamstring graft harvest are transient in most patients.
• Tunnel malposition: Non-anatomic tunnel placement — a technical error — produces persistent instability despite an intact graft. Anatomic ACL reconstruction (placing the femoral tunnel in the native ACL footprint rather than the 'transtibial' isometric position) has reduced but not eliminated this complication.

Meniscal Surgery Complications: The most significant risk of partial meniscectomy is not short-term — it is the well-documented acceleration of knee osteoarthritis from reduced meniscal coverage. Loss of the medial meniscus increases medial compartment contact stress by 75%; lateral meniscus loss increases lateral compartment stress by over 200%. These biomechanical changes translate to radiographically detectable osteoarthritis progression in the majority of young meniscectomy patients within 5-10 years. This is the primary reason why meniscal repair is always preferred over meniscectomy when technically feasible.

Cartilage Procedure Risks: Microfracture carries risk of subchondral bone cyst formation and progressive cartilage failure beyond 5 years in larger defects. MACI (two-stage) carries risks of both procedures, including risk of cultured cell infection and graft delamination. All cartilage procedures require strict post-operative rehabilitation with protected weight-bearing (6-12 weeks) to allow graft integration.

Rehabilitation after knee arthroscopy is not an afterthought — for major procedures such as ACL reconstruction and cartilage restoration, it is as important as the surgery itself in determining clinical outcome. Return-to-sport criteria have shifted from time-based to criteria-based protocols, reflecting evidence that time alone is an inadequate predictor of readiness.

Immediate Post-Operative Period (Days 1-7): Most patients are discharged the same day or within 23 hours. The knee is dressed with a compressive bandage; a cryotherapy (ice) device is applied intermittently. Weight-bearing is typically unrestricted after diagnostic procedures, loose body removal, and non-complex partial meniscectomy. After ACL reconstruction, full weight-bearing with crutches is allowed immediately in most modern protocols; full weight-bearing without crutches is achieved by 1-2 weeks. After meniscal repair or cartilage procedures, weight-bearing restriction varies (partial weight-bearing for 4-6 weeks after meniscal repair; 6-12 weeks after cartilage restoration).

ACL Reconstruction Rehabilitation Phases:

• Phase 1 (weeks 1-6): Full extension restoration (absolutely critical — extension loss is the leading cause of poor ACL outcomes), quadriceps activation, swelling management, and normalisation of gait. Range of motion exercises, closed-chain quadriceps strengthening (mini squats, leg press), and proprioception training.
• Phase 2 (weeks 6-16): Progressive strengthening, addressing quadriceps-hamstring imbalance. Limb Symmetry Index (LSI) testing — comparing strength of operated to non-operated limb — guides progression. Running is typically introduced at 3-4 months when quadriceps LSI exceeds 70%.
• Phase 3 (months 4-9): Sport-specific training — cutting, pivoting, deceleration drills. Return-to-sport decision requires: LSI greater than 90% for quadriceps and hamstrings, single-leg hop test symmetry above 90%, and psychological readiness (ACL-RSI score). Most patients achieve criteria at 9-12 months.

Return-to-Sport Criteria: The '9-month rule' — a minimum 9 months before competitive sport return — is supported by epidemiological data showing that re-rupture risk halves for each month delay in return beyond 6 months, reaching a nadir at 9+ months. Time-based return alone (before objective strength criteria are met) is associated with substantially higher re-rupture rates.

After Partial Meniscectomy: Recovery is rapid — most patients are mobilising fully at 1-2 weeks and return to light sport at 6-8 weeks. Physiotherapy focuses on quadriceps strengthening, proprioception, and swelling management. Return to contact sport at 6-12 weeks is typical for isolated meniscectomy.

The cost of knee arthroscopy varies markedly between countries and between procedures within the same country. ACL reconstruction is the most expensive common arthroscopic procedure; diagnostic arthroscopy or loose body removal is at the lower end.

United States of America: The total cost of ACL reconstruction in the USA ranges from $20,000-50,000, including surgeon fees, anaesthesiologist, operating room, implants, and post-operative care. With insurance, out-of-pocket costs (deductibles, co-insurance) are typically $1,000-5,000. Meniscal repair or partial meniscectomy costs $10,000-25,000. Cartilage procedures (MACI) are among the most expensive — $40,000-80,000 including the two stages. Physical therapy adds $3,000-8,000 over 9-12 months for ACL rehabilitation.

United Kingdom (NHS): NHS-funded arthroscopic knee surgery is available to UK residents at no direct cost. NHS waiting times for elective ACL reconstruction have historically been 6-12 months. Private orthopaedic costs in the UK: ACL reconstruction £8,000-15,000 all-inclusive; meniscal repair £5,000-9,000; partial meniscectomy £4,000-7,000.

India: At internationally accredited orthopaedic centres — Apollo Hospitals, Fortis, Kokilaben Dhirubhai Ambani Hospital, Narayana Health — ACL reconstruction costs $3,000-6,000 USD for the complete procedure including implants, hospital stay, and initial physiotherapy. Meniscal surgery costs $1,500-3,500. Cartilage procedures (MACI) cost $8,000-15,000 (the cultured chondrocyte product must be sourced internationally as local manufacturing is limited, adding cost). India is a significant destination for international patients seeking arthroscopic knee surgery, with highly trained orthopaedic surgeons — many fellowship-trained in the USA, UK, or Australia — and modern arthroscopic equipment.

Thailand: $4,000-8,000 for ACL reconstruction at JCI-accredited centres; $2,000-4,000 for meniscal procedures. Strong medical tourism infrastructure with internationally trained surgeons.

Germany: €10,000-20,000 for ACL reconstruction in private sector; publicly funded through statutory health insurance for German residents. Known for high technical standards and MACI expertise.

Implant Cost Considerations: Implant choice significantly affects procedure cost. All-inside meniscal repair devices (FasT-Fix, Meniscus Cinch) cost $300-800 each; multiple implants may be required. ACL fixation devices — titanium interference screws, cortical buttons (Endobutton, TightRope) — add $500-2,000 to implant costs. LARS synthetic ligament ($800-1,500 for the implant alone) is premium-priced. Cartilage products — MACI matrix ($1,500 for the chondrocyte seeding product in USA) — are separately billed.

For conditions where arthroscopy is traditionally indicated, evidence-based alternatives — particularly supervised exercise rehabilitation — have emerged as equally or more effective for specific presentations. Understanding these alternatives is essential for shared decision-making.

ACL Non-Operative Management: Not all ACL tears require reconstruction. Non-operative management — structured physiotherapy targeting quadriceps and hamstring strength, neuromuscular control, and proprioception — is appropriate for: inactive or sedentary individuals who can permanently modify activities to avoid pivoting; older patients with early osteoarthritis where reconstruction risks outweigh benefits; and 'copers' — a subset of patients with ACL-deficient knees who demonstrate stable function without reconstruction. The Delaware-Oslo ACL Cohort Study demonstrated that approximately 50% of ACL-injured patients managed non-operatively function satisfactorily at 2 years without surgery, though progressive meniscal and cartilage damage accumulates in those who return to sport.

Physiotherapy for Degenerative Meniscal Tears: The METEOR, FINN, and ESCAPE trials collectively demonstrate that structured physiotherapy is equivalent to arthroscopic partial meniscectomy for degenerative meniscal tears in patients over 40 with knee pain and early OA. The 2019 BMJ 'Rapid Recommendations' and Danish Society of Orthopaedics guidelines now recommend supervised exercise as the first-line treatment for this population, with surgery reserved for failure of conservative management or specific mechanical symptoms (true locking from displaced tear). This represents one of the most practice-changing evidence developments in orthopaedic surgery of the last decade.

Intra-Articular Injections: Corticosteroid injections provide short-term pain relief (6-12 weeks) for knee OA and inflammatory synovitis. Hyaluronic acid (viscosupplement) injections show modest benefit for mild-to-moderate OA in some meta-analyses; evidence is contested. Platelet-Rich Plasma (PRP) injections for OA and meniscal pathology have growing evidence from RCTs, though effect sizes are modest and preparation protocols vary widely. These are palliative, not curative, but provide meaningful short-term pain relief while awaiting surgery or as alternatives in patients not wishing to pursue arthroscopy.

Total or Partial Knee Replacement: For patients with advanced knee OA causing severe, activity-limiting pain — where arthroscopy would provide no structural benefit — knee replacement (total or unicompartmental/partial) is the definitive surgical option. Unicompartmental knee arthroplasty (UKA) for isolated medial or lateral compartment OA offers faster recovery and better proprioception preservation than total knee replacement, with equivalent 10-year survival in appropriately selected patients (Oxford Phase 3, Cementless Oxford).

Biological Augmentation of ACL Healing: The BEAR (Bridge-Enhanced ACL Repair) implant — a collagen scaffold soaked in the patient's own blood, inserted between the torn ACL ends without graft harvest — has demonstrated healing and functional outcomes comparable to traditional ACLR in the first Phase 3 trial (BEAR II, NEJM Evidence, 2023). FDA approval was granted in 2023. BEAR preserves the native ACL mechanoreceptors and avoids donor site morbidity; longer-term data on re-rupture rates versus graft reconstruction are awaited. This technology may substantially shift ACL management practice.

Osteotomy: For young active patients with knee OA in a single compartment in the context of limb malalignment, high tibial osteotomy (HTO) or distal femoral osteotomy (DFO) redistributes load away from the damaged compartment, relieving pain and potentially delaying or preventing knee replacement. Osteotomy is often combined with cartilage restoration procedures, and may be appropriate instead of or alongside arthroscopic intervention.